Newsroom

December 14, 2020

2020: A Year in Review

This proved to be a formative year in the fight against Parkinson’s. Check out ASAP’s 2020 efforts and progress in better understanding the underlying causes of PD.

Learn More
November 16, 2020

The Michael J. Fox Foundation Seeks Applications for its Edmond J. Safra Fellowship in Movement Disorders

This program funds academic medical centers worldwide to train new movement disorder clinician-researchers over a two-year period. Please note the deadline for this opportunity has now passed.

Learn More
October 1, 2020

Developing Therapies for Parkinson’s

The Lancet highlights the work we do with our AMP-PD partners in enabling meaningful progress in the development of new therapies to treat Parkinson’s disease.

Learn More
September 24, 2020

Aligning Science Across Parkinson's Awards $161 Million in Grants

Philanthropy News Digest featured ASAP in this article detailing what our grantees hope to accomplish with their research.

Learn More
September 18, 2020

Researchers Describe Details of Protein Linked to Genetically Inherited Parkinson's Disease

This article from News Medical Life Sciences highlights new studies describing unprecedented details of a protein linked to genetically inherited Parkinson's disease.

Learn More
August 3, 2020

GP2-funded PhD Studentship

Based at UCL, the PhD will involve collaboration with world leaders in PD genetics across the GP2 network. The application deadline is August 31, 2020.

Learn More
December 9, 2019

ASAP announces new resource

Global Parkinson's Genetics Program (GP2) will support the ongoing search for new genetic determinants of Parkinson's disease in diverse populations.

Learn More
September 26, 2019

ASAP and cOAlition S

ASAP is committed to making full and immediate open access a reality. The future is science without publication paywalls.

Learn More
September 25, 2019

Coordinating a new approach to basic research into Parkinson’s disease

Point of view from ASAP scientific director, Randy Schekman, PhD and managing director, Ekemini A. U. Riley, PhD.

Learn More